Venlafaxine Hydrochloride

Product NDC
50268-819
11-digit product format
502680819
Labeler code
50268
Product ID
50268-819_ed873130-8230-1fc9-e053-2a95a90a64dc
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Venlafaxine Hydrochloride
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Labeler
AvPAK
Application
ANDA203332
Marketing category
ANDA
Marketing start
2021-04-27
Marketing end
0000-00-00
Substance
VENLAFAXINE HYDROCHLORIDE
Active strength
150 mg/1
Pharmacologic classes
Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50268-819-11EA - Each50268-819a641bff6-9a6d-40a2-b069-0ecfdf6462f412021-06-02
50268-819-15EA - Each50268-81947169001-0ada-4edc-9df7-df40cb7a46a112021-06-02

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50268-819-155026808191550 BLISTER PACK in 1 BOX (50268-819-15) > 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (50268-819-11) 50 blister pack2021-04-270000-00-00NoNoCurrent